Status:
RECRUITING
Minimally-Invasive Isolated Limb Perfusion
Lead Sponsor:
Vastra Gotaland Region
Conditions:
Isolated Limb Perfusion
Eligibility:
All Genders
18+ years
Brief Summary
The aim is to analyse feasibility of a minimally-invasive isolated limb perfusion.
Detailed Description
Isolated limb perfusion (ILP) and isolated limb infusion (ILI) are treatment options for patients with in-transit metastases of melanoma and locally advanced extremity sarcomas. There are several adva...
Eligibility Criteria
Inclusion
- The patient scheduled for treatment with isolated hyperthermic perfusion
- Age over 18 years.
- Signed informed consent
Exclusion
- Re-perfusion
- Lymph node metastases
- Severe atherosclerosis
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03376126
Start Date
June 1 2016
End Date
December 31 2024
Last Update
January 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hospital
Gothenburg, Sweden, 413 45